• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . The kinetics and durability of antibody and T-cell responses to SARS-CoV-2 in children

tetano

Editor, Senior Moderator
J Infect Dis


. 2024 Jun 5:jiae301.
doi: 10.1093/infdis/jiae301. Online ahead of print. The kinetics and durability of antibody and T-cell responses to SARS-CoV-2 in children

Megan A Files[SUP] 1 [/SUP], Lauren Gentles[SUP] 2 [/SUP], Leanne Kehoe[SUP] 3 [/SUP], Amanda Adler[SUP] 3 [/SUP], Kirsten Lacombe[SUP] 3 [/SUP], Jane A Dickerson[SUP] 3 4 [/SUP], Alexander Greninger[SUP] 4 [/SUP], Alpana Waghmare[SUP] 2 3 5 [/SUP], Tarayn Fairlie[SUP] 6 [/SUP], Kimberly Pringle[SUP] 6 [/SUP], Claire M Midgley[SUP] 6 [/SUP], Melissa Briggs Hagen[SUP] 6 [/SUP], Janet A Englund[SUP] 2 3 5 [/SUP], Chetan Seshadri[SUP] 1 [/SUP]



Affiliations
Abstract

Background: The kinetics and durability of T-cell responses to SARS-CoV-2 in children are not well-characterized. We studied a cohort of children aged 6 months to 20 years with COVID-19 in whom peripheral blood mononuclear cells (PBMC) and sera were archived at approximately 1, 6, and 12 months post-symptom onset.
Methods: We compared antibody (N = 85) and T-cell responses (N = 26) to nucleocapsid (N) and spike (S) glycoprotein over time across four age strata: 6 months to 5 years, 5-9, 10-14, and 15-20 years.
Results: N-specific antibody responses declined over time, becoming undetectable in 26/32 (81%) children by approximately one year post-infection. Functional breadth of anti-N CD4+ T-cell responses also declined over time and were positively correlated with N-antibody responses (Pearson's r = 0.31, p = 0.008). CD4+ T-cell responses to S displayed greater functional breadth than N in unvaccinated children, and, along with neutralization titers, were stable over time and similar across age strata. Functional profiles of CD4+ T-cell responses against S were not significantly modulated by vaccination.
Conclusions: Our data reveal durable, age-independent T-cell immunity to SARS-CoV-2 structural proteins in children over time following COVID-19 infection as well as S-Ab responses overall, in comparison to declining antibody responses to N.

Keywords: COVID-19; SARS-COV-2 Nucleocapsid antibody; SARS-COV-2 Spike antibody; SARS-CoV-2 infection; SARS-CoV-2 neutralizing antibody; T-cell immunity to SARS-CoV-2; antibody; children.

 
Back
Top Bottom